Deep learning is machine learning that analyzes large volumes of labeled and unlabeled data along with multi-dimensional and complex data with non-trivial patterns.
Market Analysis and Insights: Global Deep Learning in Drug Discovery and Diagnostics Market
The global Deep Learning in Drug Discovery and Diagnostics market is projected to grow from US$ 8522 million in 2023 to US$ 44070 million by 2029, at a Compound Annual Growth Rate (CAGR) of 31.5% during the forecast period.
The US & Canada market for Deep Learning in Drug Discovery and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Deep Learning in Drug Discovery and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Deep Learning in Drug Discovery and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Deep Learning in Drug Discovery and Diagnostics include Google Inc., IBM Corp., Microsoft Corporation, Qualcomm Technologies, General Vision, Insilico Medicine, NVIDIA Corporation, Zebra Medical Vision and Enlitic, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Deep Learning in Drug Discovery and Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Deep Learning in Drug Discovery and Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Deep Learning in Drug Discovery and Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Deep Learning in Drug Discovery and Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Deep Learning in Drug Discovery and Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Deep Learning in Drug Discovery and Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Google Inc., IBM Corp., Microsoft Corporation, Qualcomm Technologies, General Vision, Insilico Medicine, NVIDIA Corporation, Zebra Medical Vision and Enlitic, etc.
By Company
Google Inc.
IBM Corp.
Microsoft Corporation
Qualcomm Technologies
General Vision
Insilico Medicine
NVIDIA Corporation
Zebra Medical Vision
Enlitic
Ginger.io
MedAware
Lumiata
Segment by Type
Drug Discovery
Diagnostics
Forensic Interventions
Others
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations
Healthcare IT
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Deep Learning in Drug Discovery and Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deep Learning in Drug Discovery and Diagnostics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Deep Learning in Drug Discovery and Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deep Learning in Drug Discovery and Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Drug Discovery
1.2.3 Diagnostics
1.2.4 Forensic Interventions
1.2.5 Others
1.3 Market by Application
1.3.1 Global Deep Learning in Drug Discovery and Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Contract Research Organizations
1.3.5 Healthcare IT
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Deep Learning in Drug Discovery and Diagnostics Market Perspective (2018-2029)
2.2 Global Deep Learning in Drug Discovery and Diagnostics Growth Trends by Region
2.2.1 Deep Learning in Drug Discovery and Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Deep Learning in Drug Discovery and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Deep Learning in Drug Discovery and Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Deep Learning in Drug Discovery and Diagnostics Market Dynamics
2.3.1 Deep Learning in Drug Discovery and Diagnostics Industry Trends
2.3.2 Deep Learning in Drug Discovery and Diagnostics Market Drivers
2.3.3 Deep Learning in Drug Discovery and Diagnostics Market Challenges
2.3.4 Deep Learning in Drug Discovery and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Deep Learning in Drug Discovery and Diagnostics by Players
3.1.1 Global Deep Learning in Drug Discovery and Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Deep Learning in Drug Discovery and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Deep Learning in Drug Discovery and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Deep Learning in Drug Discovery and Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Deep Learning in Drug Discovery and Diagnostics Market Concentration Ratio
3.4.1 Global Deep Learning in Drug Discovery and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deep Learning in Drug Discovery and Diagnostics Revenue in 2022
3.5 Global Key Players of Deep Learning in Drug Discovery and Diagnostics Head office and Area Served
3.6 Global Key Players of Deep Learning in Drug Discovery and Diagnostics, Product and Application
3.7 Global Key Players of Deep Learning in Drug Discovery and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Deep Learning in Drug Discovery and Diagnostics Breakdown Data by Type
4.1 Global Deep Learning in Drug Discovery and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Deep Learning in Drug Discovery and Diagnostics Forecasted Market Size by Type (2024-2029)
5 Deep Learning in Drug Discovery and Diagnostics Breakdown Data by Application
5.1 Global Deep Learning in Drug Discovery and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Deep Learning in Drug Discovery and Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Deep Learning in Drug Discovery and Diagnostics Market Size (2018-2029)
6.2 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Type
6.2.1 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Deep Learning in Drug Discovery and Diagnostics Market Share by Type (2018-2029)
6.3 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Application
6.3.1 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Deep Learning in Drug Discovery and Diagnostics Market Share by Application (2018-2029)
6.4 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Country
6.4.1 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Deep Learning in Drug Discovery and Diagnostics Market Size (2018-2029)
7.2 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Type
7.2.1 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Deep Learning in Drug Discovery and Diagnostics Market Share by Type (2018-2029)
7.3 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Application
7.3.1 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Deep Learning in Drug Discovery and Diagnostics Market Share by Application (2018-2029)
7.4 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Country
7.4.1 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Deep Learning in Drug Discovery and Diagnostics Market Size (2018-2029)
8.2 China Deep Learning in Drug Discovery and Diagnostics Market Size by Type
8.2.1 China Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2018-2023)
8.2.2 China Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2024-2029)
8.2.3 China Deep Learning in Drug Discovery and Diagnostics Market Share by Type (2018-2029)
8.3 China Deep Learning in Drug Discovery and Diagnostics Market Size by Application
8.3.1 China Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2018-2023)
8.3.2 China Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2024-2029)
8.3.3 China Deep Learning in Drug Discovery and Diagnostics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Deep Learning in Drug Discovery and Diagnostics Market Size (2018-2029)
9.2 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Type
9.2.1 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Deep Learning in Drug Discovery and Diagnostics Market Share by Type (2018-2029)
9.3 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Application
9.3.1 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Deep Learning in Drug Discovery and Diagnostics Market Share by Application (2018-2029)
9.4 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Region
9.4.1 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Deep Learning in Drug Discovery and Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Deep Learning in Drug Discovery and Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Google Inc.
11.1.1 Google Inc. Company Details
11.1.2 Google Inc. Business Overview
11.1.3 Google Inc. Deep Learning in Drug Discovery and Diagnostics Introduction
11.1.4 Google Inc. Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.1.5 Google Inc. Recent Developments
11.2 IBM Corp.
11.2.1 IBM Corp. Company Details
11.2.2 IBM Corp. Business Overview
11.2.3 IBM Corp. Deep Learning in Drug Discovery and Diagnostics Introduction
11.2.4 IBM Corp. Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.2.5 IBM Corp. Recent Developments
11.3 Microsoft Corporation
11.3.1 Microsoft Corporation Company Details
11.3.2 Microsoft Corporation Business Overview
11.3.3 Microsoft Corporation Deep Learning in Drug Discovery and Diagnostics Introduction
11.3.4 Microsoft Corporation Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.3.5 Microsoft Corporation Recent Developments
11.4 Qualcomm Technologies
11.4.1 Qualcomm Technologies Company Details
11.4.2 Qualcomm Technologies Business Overview
11.4.3 Qualcomm Technologies Deep Learning in Drug Discovery and Diagnostics Introduction
11.4.4 Qualcomm Technologies Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.4.5 Qualcomm Technologies Recent Developments
11.5 General Vision
11.5.1 General Vision Company Details
11.5.2 General Vision Business Overview
11.5.3 General Vision Deep Learning in Drug Discovery and Diagnostics Introduction
11.5.4 General Vision Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.5.5 General Vision Recent Developments
11.6 Insilico Medicine
11.6.1 Insilico Medicine Company Details
11.6.2 Insilico Medicine Business Overview
11.6.3 Insilico Medicine Deep Learning in Drug Discovery and Diagnostics Introduction
11.6.4 Insilico Medicine Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.6.5 Insilico Medicine Recent Developments
11.7 NVIDIA Corporation
11.7.1 NVIDIA Corporation Company Details
11.7.2 NVIDIA Corporation Business Overview
11.7.3 NVIDIA Corporation Deep Learning in Drug Discovery and Diagnostics Introduction
11.7.4 NVIDIA Corporation Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.7.5 NVIDIA Corporation Recent Developments
11.8 Zebra Medical Vision
11.8.1 Zebra Medical Vision Company Details
11.8.2 Zebra Medical Vision Business Overview
11.8.3 Zebra Medical Vision Deep Learning in Drug Discovery and Diagnostics Introduction
11.8.4 Zebra Medical Vision Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.8.5 Zebra Medical Vision Recent Developments
11.9 Enlitic
11.9.1 Enlitic Company Details
11.9.2 Enlitic Business Overview
11.9.3 Enlitic Deep Learning in Drug Discovery and Diagnostics Introduction
11.9.4 Enlitic Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.9.5 Enlitic Recent Developments
11.10 Ginger.io
11.10.1 Ginger.io Company Details
11.10.2 Ginger.io Business Overview
11.10.3 Ginger.io Deep Learning in Drug Discovery and Diagnostics Introduction
11.10.4 Ginger.io Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.10.5 Ginger.io Recent Developments
11.11 MedAware
11.11.1 MedAware Company Details
11.11.2 MedAware Business Overview
11.11.3 MedAware Deep Learning in Drug Discovery and Diagnostics Introduction
11.11.4 MedAware Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.11.5 MedAware Recent Developments
11.12 Lumiata
11.12.1 Lumiata Company Details
11.12.2 Lumiata Business Overview
11.12.3 Lumiata Deep Learning in Drug Discovery and Diagnostics Introduction
11.12.4 Lumiata Revenue in Deep Learning in Drug Discovery and Diagnostics Business (2018-2023)
11.12.5 Lumiata Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Google Inc.
IBM Corp.
Microsoft Corporation
Qualcomm Technologies
General Vision
Insilico Medicine
NVIDIA Corporation
Zebra Medical Vision
Enlitic
Ginger.io
MedAware
Lumiata
听
听
*If Applicable.
